ONTOLOGY REPORT - ANNOTATIONS
| Term: | thimerosal |
|
| Accession: | CHEBI:9546
|
browse the term
|
| Definition: | An organomercury compound (approximately 49% mercury by weight) used as an antiseptic and antifungal agent. |
| Synonyms: | exact_synonym: | sodium [(2-carboxylatophenyl)sulfanyl](ethyl)mercurate(1-); sodium ethyl[2-(sulfanyl-kappaS)benzoato(2-)]mercurate(1-) |
| | related_synonym: | C9H9HgNaO2S; C9H9HgO2S.Na; InChI=1S/C7H6O2S.C2H5.Hg.Na/c8-7(9)5-3-1-2-4-6(5)10;1-2;;/h1-4,10H,(H,8,9);1H2,2H3;;/q;;2*+1/p-2; InChIKey=RTKIYNMVFMVABJ-UHFFFAOYSA-L; Merthiolate; Thiomersal; [(o-carboxyphenyl)thio]ethylmercury sodium salt; [Na+].CC[Hg]Sc1ccccc1C([O-])=O; ethyl(2-mercaptobenzoato-S)mercury sodium salt; ethylmercurithiosalicylate sodium; mercurothiolate; o-(ethylmercurithio)benzoic acid sodium salt; thiomersalate |
| | xref_casrn: | 54-64-8 |
| | xref: | Beilstein:8169555 "Beilstein Registry Number"; ChEMBL:545859 "ChEMBL COMPOUND"; ChemIDplus:54-64-8 "CAS Registry Number"; CiteXplore:18837732 "PubMed citation"; CiteXplore:21616561 "PubMed citation"; Gmelin:1677155 "Gmelin Registry Number"; KEGG COMPOUND:C08044 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D013849 |
|
|
thimerosal
|
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
increases secretion |
ISO |
X |
45,828,121 |
45,866,603 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Arc |
activity regulated cytoskeletal-associated protein |
|
increases expression |
ISO |
15 |
74,499,513 |
74,503,000 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
1 |
192,994,175 |
193,007,212 |
RGD:6480464 |
CTD |
| G |
Bag3 |
BCL2-associated athanogene 3 |
|
increases expression |
ISO |
7 |
135,667,097 |
135,690,495 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases cleavage |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Cd28 |
CD28 antigen |
|
affects response to substance |
EXP |
1 |
60,803,232 |
60,830,203 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
increases expression |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
multiple interactions |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
multiple interactions |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
increases expression |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
increases expression |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
increases expression |
ISO |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
10 |
126,500,659 |
126,504,339 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
ISO |
10 |
17,443,034 |
17,445,480 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
|
increases expression |
ISO |
19 |
37,095,781 |
37,281,783 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
ISO |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine rich protein 61 |
|
increases expression |
ISO |
3 |
145,309,935 |
145,312,949 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
8 |
86,132,074 |
86,135,802 |
RGD:6480464 |
CTD |
| G |
Dnajb4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
|
increases expression |
ISO |
3 |
151,846,919 |
151,873,263 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
17 |
26,642,536 |
26,645,417 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
increases expression |
ISO |
7 |
19,888,045 |
19,895,394 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
|
increases expression |
ISO |
13 |
51,942,044 |
51,943,844 |
RGD:6480464 |
CTD |
| G |
Gemin4 |
gem (nuclear organelle) associated protein 4 |
|
decreases expression |
ISO |
11 |
76,024,073 |
76,031,074 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
|
affects expression |
EXP |
7 |
25,794,868 |
25,857,388 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
decreases expression |
EXP |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
|
decreases expression |
EXP |
6 |
135,679,813 |
136,123,529 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase, mu 1 |
|
affects response to substance |
ISO |
3 |
107,815,168 |
107,820,891 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase, theta 1 |
|
affects response to substance |
ISO |
10 |
75,246,558 |
75,261,329 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
36,664,581 |
36,675,459 |
RGD:6480464 |
CTD |
| G |
Hist1h3b |
histone cluster 1, H3b |
|
increases expression |
ISO |
13 |
23,844,249 |
23,844,659 |
RGD:6480464 |
CTD |
| G |
Hist1h3g |
histone cluster 1, H3g |
|
increases expression |
ISO |
13 |
23,627,287 |
23,627,778 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
increases expression |
ISO |
17 |
35,109,648 |
35,116,173 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects response to substance |
EXP |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
11 |
53,534,296 |
53,538,605 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects response to substance |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Kansl1l |
KAT8 regulatory NSL complex subunit 1-like |
|
increases expression |
ISO |
1 |
66,765,817 |
66,864,169 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
4 |
55,540,009 |
55,545,347 |
RGD:6480464 |
CTD |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
|
increases expression |
ISO |
2 |
160,189,413 |
160,192,801 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
increases phosphorylation |
ISO |
17 |
28,828,287 |
28,885,350 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Med18 |
mediator of RNA polymerase II transcription, subunit 18 homolog (yeast) |
|
decreases expression |
ISO |
4 |
132,014,644 |
132,019,836 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
affects expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
EXP |
8 |
96,676,507 |
96,678,048 |
RGD:6480464 |
CTD |
| G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
multiple interactions |
ISO |
13 |
12,279,086 |
12,350,267 |
RGD:6480464 |
CTD |
| G |
Mxd1 |
MAX dimerization protein 1 |
|
increases expression |
ISO |
6 |
86,597,038 |
86,619,153 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor |
|
multiple interactions |
ISO |
3 |
102,273,851 |
102,324,936 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor |
|
decreases response to substance |
ISO |
3 |
102,273,851 |
102,324,936 |
RGD:6480464 |
CTD |
| G |
Npat |
nuclear protein in the AT region |
|
increases expression |
ISO |
9 |
53,345,152 |
53,383,732 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
ISO |
2 |
56,959,637 |
56,976,414 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
multiple interactions |
ISO |
3 |
87,582,166 |
87,599,084 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
increases expression |
ISO |
12 |
86,507,591 |
86,518,235 |
RGD:6480464 |
CTD |
| G |
Phf20l1 |
PHD finger protein 20-like 1 |
|
decreases expression |
ISO |
15 |
66,409,134 |
66,476,817 |
RGD:6480464 |
CTD |
| G |
Plcg1 |
phospholipase C, gamma 1 |
|
increases cleavage |
ISO |
2 |
160,557,046 |
160,601,496 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
increases expression |
ISO |
13 |
111,185,252 |
111,191,052 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
increases response to substance |
ISO |
15 |
73,035,535 |
73,253,621 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
|
multiple interactions |
ISO |
15 |
73,035,535 |
73,253,621 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
increases expression |
ISO |
8 |
107,151,966 |
107,155,221 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
increases expression |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
|
increases expression |
ISO |
7 |
106,493,885 |
106,501,749 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
EXP |
19 |
28,909,656 |
28,988,450 |
RGD:6480464 |
CTD |
| G |
Tmod2 |
tropomodulin 2 |
|
increases expression |
ISO |
9 |
75,413,428 |
75,459,132 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases activity |
ISO |
11 |
98,854,261 |
98,885,503 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
increases expression |
ISO |
11 |
9,018,011 |
9,036,173 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
affects expression |
ISO |
X |
39,421,013 |
39,462,841 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
39,421,013 |
39,462,841 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
39,421,013 |
39,462,841 |
RGD:6480464 |
CTD |
Term paths to the root
|